Pantoloc (Pantoprazole)

Pantoprazole, the active ingredient in Pantoloc, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoloc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the acid‑secretion pathway of the stomach. It is indicated for several gastrointestinal disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Erosive esophagitis: heals erosive lesions and prevents further damage. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens (as adjunct): enhances eradication success when combined with antibiotics.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence: excess gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Acute interstitial nephritis: inflammation of kidney tissue. - Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Clostridioides difficile infection: persistent diarrhea with possible colitis. - Low magnesium levels (hypomagnesemia): may cause muscle cramps or arrhythmia. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatic stress.

When prescribing Pantoloc, clinicians should consider several safety aspects: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for interaction with drugs requiring gastric acidity. - Monitor long‑term use: evaluate need for continued therapy after 8‑12 weeks. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Pantoprazole can affect the absorption and metabolism of several medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Methotrexate (high dose): reduced renal clearance; check serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity.